The COVID-19 pandemic highlighted the importance of health care and the role biopharma companies play in drug and vaccine development. As a result, the sector grew tremendously...
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or...
"The global health industry was worth $8.45 trillion in 2018 and global healthcare could reach over $10 trillion by 2022," according to PolicyAdvice a US insurance specialist. And...
Over the past several months healthcare has become a top priority for individuals and governments alike around the globe. Many now regard a potential drug, or a vaccine, as a...
The U.S. stock market finished May with a flourish and could have room to move even higher. Prices and trading volumes were strong, especially in the final week of the month as...
It was a terrific April for stocks. Nonetheless, it left investors with a lot of significant questions. The most important: do you actually believe what the markets are saying?...
We set out today to create a global balanced portfolio using 16 ETFs picked from the circa 200 available on our platform. Our investment horizon is the next 3 to 6 months, or...